Aim Results from clinical trials support the use of oral antipsychotics for treatment of early or
first‐episode psychosis in patients with schizophrenia. This paper will review literature on …

Patients with schizophrenia are often unaware of their condition and the consequences of
their illness. This lack of insight results in impaired functioning, treatment non-adherence …

Since the original publication of Traumatic Brain Injury: Methods for Clinical & Forensic
Neuropsychiatric Assessment, enhanced clinical findings concerning traumatic brain injury …

Background The efficacy of fronto-temporal transcranial direct current stimulation in treating
auditory verbal hallucinations and other psychopathological symptoms of schizophrenia …

Abstract Objective The Medication Adherence Rating Scale (MARS) is one of the most
widely used measurements of adherence in schizophrenia (SZ). However, the data …

Sažetak Poor insight and high level of self-stigma are often present among patients with
schizophrenia and are related to poorer treatment adherence, poorer social function and …

Assessing Psychosis: A Clinician's Guide offers both a practical guide and rich clinical
resource for a broad audience of mental-health practitioners seeking to sharpen their …

Background Identifying risk factors for suicidal ideation and attempt among first-episode
psychosis patients is essential to prevent suicide in this high-risk population. We …

Impaired clinical insight (CI) is a common symptom of psychotic disorders and a promising
treatment target. However, to date, our understanding of how variability in CI is tied to …

Aims: The aim of this study was to evaluate the subjective cognitive complaints (SCCs) and
their relation to objective cognitive performance, clinical profile, clinical insight, and social …